InvestorsHub Logo
Followers 50
Posts 12100
Boards Moderated 0
Alias Born 06/15/2014

Re: None

Monday, 12/09/2024 4:40:50 PM

Monday, December 09, 2024 4:40:50 PM

Post# of 431884
One thing that strikes me when re-reading the complaint here:
https://ia601807.us.archive.org/4/items/gov.uscourts.ded.73924/gov.uscourts.ded.73924.1.0.pdf

Is that I clearly would agree with the magistrate judge that the case should have gone forward and NOT dismissed. As JRoon states, it is not a given how any court would interpret all the details of the case, but to me it is clear that the original action should have gone to trial and not dismissed.

Amongst all the details, one thing that I found to be fairly egregious, was Hikma indicating that their drug was AB rated (therapeutically equivalent) to Vascepa for hypertriglyceridemia. That of course is totally false and it is only AB rated for Severe Hypertriglyceridemia.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News